Tweets by 2022 IKCS: North America

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Full Schedule

Home
Full Schedule

All Days
Thu, Nov 3
Fri, Nov 4
Sat, Nov 5

Full Schedule

Type here to filter the list

Saturday, November 5, 2022
6:30 AM – 7:15 AM CDT
Run (In-person Only, Advance Registration Required)

6:30 AM – 7:15 AM CDT

Run (In-person Only, Advance Registration Required)
Location: Hyatt Hotel Lobby

In-person Only Session

Favorite

6:30 AM – 7:30 AM CDT
Yoga (In-person Only, Advance Purchase Required)

6:30 AM – 7:30 AM CDT

Yoga (In-person Only, Advance Purchase Required)
Location: Big Bend Ballroom

In-person Only Session

Favorite

6:30 AM – 2:00 PM CDT
Poster and Exhibit Hall Open

6:30 AM – 2:00 PM CDT

Poster and Exhibit Hall Open
Location: Zilker North Foyer and Zilker 1-2

Poster Session

Favorite

6:30 AM – 2:00 PM CDT
Registration Open

6:30 AM – 1:00 PM CDT

Registration Open

Favorite

7:45 AM – 8:15 AM CDT
Breakfast

7:45 AM – 8:15 AM CDT

Breakfast
Location: Hill Country Foyer and Zilker Foyer

Favorite

8:00 AM – 8:15 AM CDT
Welcome to Day 2 and Updates from the Kidney Cancer Association

8:00 AM – 8:15 AM CDT

Welcome to Day 2 and Updates from the Kidney Cancer Association
Location: Zilker 3-4

Speaker: Daniel J. George, MD – Duke University Medical Center

CME Session

Hybrid Session

Favorite

Daniel J. George, MD – Duke University Medical Center ### 1570692###Speaker###Professor of Medicine and Surgery###Duke University Medical Center###
Speaker: Daniel J. George, MD – Duke University Medical Center
###

8:15 AM – 9:15 AM CDT
Session 8: Regulatory for New Trials
Chair: Sumanta Kumar Pal, FASCO – City of Hope
CME Session
Hybrid Session

8:15 AM – 9:15 AM CDT

Session 8: Regulatory for New Trials
Location: Zilker 3-4

Chair: Sumanta Kumar Pal, FASCO – City of Hope

CME Session

Hybrid Session

Favorite

Sumanta Kumar Pal, FASCO – City of Hope ### 1678504###Chair###Professor, Dept of Medical Oncology & Therapeutic Research###City of Hope###
Chair: Sumanta Kumar Pal, FASCO – City of Hope
###

8:16 AM – 8:17 AM CDT

Introduction
Location: Zilker 3-4

Speaker: Sumanta Kumar Pal, FASCO – City of Hope

CME Session

Hybrid Session

Favorite

Sumanta Kumar Pal, FASCO – City of Hope ### 1678504###Speaker###Professor, Dept of Medical Oncology & Therapeutic Research###City of Hope###
Speaker: Sumanta Kumar Pal, FASCO – City of Hope
###

8:17 AM – 8:30 AM CDT

FDA 101: Illuminating the Black Box
Location: Zilker 3-4

Speaker: Elaine Chang, MD – United States Food and Drug Administration

CME Session

Hybrid Session

Favorite

Elaine Chang, MD – United States Food and Drug Administration ### 1756311###Speaker###Physician###United States Food and Drug Administration###
Speaker: Elaine Chang, MD – United States Food and Drug Administration
###

8:30 AM – 8:43 AM CDT

Choosing Endpoints and Designs of Future Trials
Location: Zilker 3-4

Speaker: Chung-Han Lee, BS, PhD, MD – Memorial Sloan Kettering Cancer Center

CME Session

Hybrid Session

Favorite

Chung-Han Lee, BS, PhD, MD – Memorial Sloan Kettering Cancer Center ### 1678507###Speaker###Assistant Attending Physician###Memorial Sloan Kettering Cancer Center###
Speaker: Chung-Han Lee, BS, PhD, MD – Memorial Sloan Kettering Cancer Center
###

8:43 AM – 8:56 AM CDT

Experiences With Patient Acceptance of Clinical Trials
Location: Zilker 3-4

Speaker: Laura S. Wood, RN, MSN, OCN – Retired, Cleveland Clinic Cancer Center

CME Session

Hybrid Session

Favorite

Laura S. Wood, RN, MSN, OCN – Retired, Cleveland Clinic Cancer Center ### 1600692###Speaker###Oncology Nurse Specialist###Retired, Cleveland Clinic Cancer Center###
Speaker: Laura S. Wood, RN, MSN, OCN – Retired, Cleveland Clinic Cancer Center
###

8:56 AM – 9:03 AM CDT

3: Critical assessment of eligibility criteria in contemporary renal cell carcinoma (RCC) trials evaluating systemic therapy
Location: Zilker 3-4

Oral Abstract Presenter: Daniela V. Castro, MS – City of Hope Comprehensive Cancer Center

Other

CME Session

Hybrid Session

Favorite

Daniela V. Castro, MS – City of Hope Comprehensive Cancer Center ### 1777855###Oral Abstract Presenter###Clinical Research Assistant###City of Hope Comprehensive Cancer Center###
Oral Abstract Presenter: Daniela V. Castro, MS – City of Hope Comprehensive Cancer Center
###

9:04 AM – 9:15 AM CDT

Panel Discussion and Q+A
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

9:15 AM – 10:00 AM CDT
Session 9: Oral Abstract Session
Chair: Yousef Zakharia, MD – University of Iowa
CME Session
Hybrid Session

9:15 AM – 10:00 AM CDT

Session 9: Oral Abstract Session
Location: Zilker 3-4

Chair: Yousef Zakharia, MD – University of Iowa

CME Session

Hybrid Session

Favorite

Yousef Zakharia, MD – University of Iowa ### 1678485###Chair###Associate Professor of Medicine ###University of Iowa###
Chair: Yousef Zakharia, MD – University of Iowa
###

9:16 AM – 9:23 AM CDT

5: CD200-mediated immune evasion in clear cell renal cell carcinoma
Location: Zilker 3-4

Alternate Presenter: Girish Patel, MD (he/him/his) – Cardiff University

Oral Abstract Presenter: Gemma E. Davies, MSc, BSc – Cardiff University

Basic Science

CME Session

Hybrid Session

Favorite

Girish Patel, MD (he/him/his) – Cardiff University ### 1806362###Alternate Presenter###Prinicipal Investigator###Cardiff University###
Alternate Presenter: Girish Patel, MD (he/him/his) – Cardiff University
### he/him/his @@@ Gemma E. Davies, MSc, BSc – Cardiff University ### 1777850###Oral Abstract Presenter###PhD Student###Cardiff University###
Oral Abstract Presenter: Gemma E. Davies, MSc, BSc – Cardiff University
###

9:24 AM – 9:31 AM CDT

6: Clinical outcomes with nivolumab/ipilimumab (nivo/ipi) with or without CBM588 in metastatic renal cell carcinoma (mRCC): Long-term follow-up of a randomized phase Ib clinical trial
Location: Zilker 3-4

Oral Abstract Presenter: Nazli Dizman, MD – Yale New Haven Hospital

Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)

CME Session

Hybrid Session

Favorite

Nazli Dizman, MD – Yale New Haven Hospital ### 1777857###Oral Abstract Presenter###Internal Medicine Resident###Yale New Haven Hospital###
Oral Abstract Presenter: Nazli Dizman, MD – Yale New Haven Hospital
###

9:32 AM – 9:39 AM CDT

7: Assessment of Clavien-Dindo Classification in patients with Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) who received Perioperative Cabozantinib and Nivolumab on Cyto-KIK Clinical Trial
Location: Zilker 3-4

Oral Abstract Presenter: Karie Runcie, Assistant Professor of Medicine – New York Presbyterian Hospital- Columbia University

Therapeutics- Systemic (Ablation, Interventional Radiology, Medical Oncology, Radiation Therapy, Surgery, Urology)

CME Session

Hybrid Session

Favorite

Karie Runcie, Assistant Professor of Medicine – New York Presbyterian Hospital- Columbia University ### 1777853###Oral Abstract Presenter###Medical Oncologist###New York Presbyterian Hospital- Columbia University###
Oral Abstract Presenter: Karie Runcie, Assistant Professor of Medicine – New York Presbyterian Hospital- Columbia University
###

9:40 AM – 9:47 AM CDT

8: Genetic Ancestry and Molecular Correlations in Patients with Kidney Cancers
Location: Zilker 3-4

Oral Abstract Presenter: Ritesh Kotecha, MD – Memorial Sloan Kettering Cancer Center

Tumor Biology, Biomarkers, and Pathology

CME Session

Hybrid Session

Favorite

Ritesh Kotecha, MD – Memorial Sloan Kettering Cancer Center ### 1777854###Oral Abstract Presenter###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Oral Abstract Presenter: Ritesh Kotecha, MD – Memorial Sloan Kettering Cancer Center
###

9:48 AM – 10:00 AM CDT

Panel Discussion and Q+A

Favorite

10:00 AM – 10:05 AM CDT
Patient Perspective: Tom Cady

10:00 AM – 10:05 AM CDT

Patient Perspective: Tom Cady

Favorite

10:05 AM – 10:15 AM CDT
Break

10:05 AM – 10:15 AM CDT

Break

Favorite

10:15 AM – 11:45 AM CDT
Session 10: Genetics in Kidney Cancer Demonstrated Through Case-Based Presentations
Chair: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center
CME Session
Hybrid Session

10:15 AM – 11:45 AM CDT

Session 10: Genetics in Kidney Cancer Demonstrated Through Case-Based Presentations
Location: Zilker 3-4

Chair: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center

CME Session

Hybrid Session

Favorite

Maria Carlo, MD – Memorial Sloan Kettering Cancer Center ### 1678480###Chair###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Chair: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center
###

10:16 AM – 10:17 AM CDT

Introduction
Location: Zilker 3-4

Speaker: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center

CME Session

Hybrid Session

Favorite

Maria Carlo, MD – Memorial Sloan Kettering Cancer Center ### 1678480###Speaker###Assistant Attending###Memorial Sloan Kettering Cancer Center###
Speaker: Maria Carlo, MD – Memorial Sloan Kettering Cancer Center
###

10:17 AM – 10:35 AM CDT

Considerations for the Genetics Consensus Statement and Who/What/When/Where/Why of Genetics in Kidney Cancer and Case Presentations Illustrating Options
Location: Zilker 3-4

Speaker: Brian Shuch – University of California, Los Angeles

CME Session

Hybrid Session

Favorite

Brian Shuch – University of California, Los Angeles ### 1678508###Speaker######University of California, Los Angeles###
Speaker: Brian Shuch – University of California, Los Angeles
###

10:35 AM – 10:55 AM CDT

Somatic Genetic Testing: Lessons from Tuberous Sclerosis Complex and Birt Hogg Dube Syndrome
Location: Zilker 3-4

Speaker: Elizabeth Henske, MD – Brigham and Women's Hospital

CME Session

Hybrid Session

Favorite

Elizabeth Henske, MD – Brigham and Women's Hospital ### 1678509###Speaker###Professor###Brigham and Women's Hospital###
Speaker: Elizabeth Henske, MD – Brigham and Women's Hospital
###

10:55 AM – 11:15 AM CDT

Genetic of Kidney Cancer: Systemic Therapy for VHL and HLRCC-Associated Cancers
Location: Zilker 3-4

Speaker: Ramprasad Srinivasan, MD, PhD – National Cancer Institute at the National Institutes of Health

CME Session

Hybrid Session

Favorite

Ramprasad Srinivasan, MD, PhD – National Cancer Institute at the National Institutes of Health ### 1678510###Speaker###Investigator and Head, Molecular Cancer Section ###National Cancer Institute at the National Institutes of Health###
Speaker: Ramprasad Srinivasan, MD, PhD – National Cancer Institute at the National Institutes of Health
###

11:15 AM – 11:22 AM CDT

4: Delineating Clinical and Radiologic Features of Rare Kidney Cancer Genetic Syndromes
Location: Zilker 3-4

Oral Abstract Presenter: Pamela I. Causa Andrieu, MD – Memorial Sloan Kettering Cancer

Imaging

CME Session

Hybrid Session

Favorite

Pamela I. Causa Andrieu, MD – Memorial Sloan Kettering Cancer ### 1777851###Oral Abstract Presenter###Instructor###Memorial Sloan Kettering Cancer###
Oral Abstract Presenter: Pamela I. Causa Andrieu, MD – Memorial Sloan Kettering Cancer
###

11:23 AM – 11:45 AM CDT

Panel Discussion and Q+A
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

11:45 AM – 12:30 PM CDT
Session 11: Risk Stratification: Considerations and the Evolving State of RCC
Chair: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center
CME Session
Hybrid Session

11:45 AM – 12:30 PM CDT

Session 11: Risk Stratification: Considerations and the Evolving State of RCC
Location: Zilker 3-4

Chair: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center

CME Session

Hybrid Session

Favorite

Katy Beckermann, MD, PhD – Vanderbilt University Medical Center ### 1570715###Chair###Assistant Professor###Vanderbilt University Medical Center###
Chair: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center
###

11:46 AM – 11:47 AM CDT

Introduction
Location: Zilker 3-4

Speaker: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center

CME Session

Hybrid Session

Favorite

Katy Beckermann, MD, PhD – Vanderbilt University Medical Center ### 1570715###Speaker###Assistant Professor###Vanderbilt University Medical Center###
Speaker: Katy Beckermann, MD, PhD – Vanderbilt University Medical Center
###

11:47 AM – 12:00 PM CDT

Renal Cell Carcinoma Prognostic Factors
Location: Zilker 3-4

Speaker: Daniel YC Heng, MD – Tom Baker Cancer Centre, Calgary, AB, Canada

CME Session

Hybrid Session

Favorite

Daniel YC Heng, MD – Tom Baker Cancer Centre, Calgary, AB, Canada ### 1678511###Speaker###Professor and Head, Medical Oncology###Tom Baker Cancer Centre, Calgary, AB, Canada###
Speaker: Daniel YC Heng, MD – Tom Baker Cancer Centre, Calgary, AB, Canada
###

12:00 PM – 12:15 PM CDT

Evolving Concepts of Risk Stratification in MRCC
Location: Zilker 3-4

Speaker: Ari Hakimi – Memorial Sloan Kettering Cancer Center

CME Session

Hybrid Session

Favorite

Ari Hakimi – Memorial Sloan Kettering Cancer Center ### 1678512###Speaker######Memorial Sloan Kettering Cancer Center###
Speaker: Ari Hakimi – Memorial Sloan Kettering Cancer Center
###

12:15 PM – 12:30 PM CDT

Discussion and Q+A
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

12:30 PM – 1:30 PM CDT
Break and Lunch Available

12:30 PM – 1:30 PM CDT

Break and Lunch Available
Location: Zilker North Foyer

Favorite

12:45 PM – 1:25 PM CDT
Session 12: Kidney Cancer Association Awards Recognition
CME Session
Hybrid Session

12:45 PM – 1:15 PM CDT

Session 12: Kidney Cancer Association Awards Recognition
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

Bradley C. Leibovich, MD – Mayo Clinic ### 1678492###Chair###Professor of Urology###Mayo Clinic###
Chair: Bradley C. Leibovich, MD – Mayo Clinic
###

12:46 PM – 12:50 PM CDT

Introduction: Eugene P. Schonfeld Award
Location: Zilker 3-4

Speaker: Bradley C. Leibovich, MD – Mayo Clinic

CME Session

Hybrid Session

Favorite

Bradley C. Leibovich, MD – Mayo Clinic ### 1678492###Speaker###Professor of Urology###Mayo Clinic###
Speaker: Bradley C. Leibovich, MD – Mayo Clinic
###

12:50 PM – 12:55 PM CDT

Eugene P. Schonfeld Award Presentation
Location: Zilker 3-4

Award Recipient : David McDermott, MD – Beth Israel Deaconess Medical Center

CME Session

Hybrid Session

Favorite

David McDermott, MD – Beth Israel Deaconess Medical Center ### 1741341###Award Recipient ###Chief of Medical Oncology###Beth Israel Deaconess Medical Center###
Award Recipient : David McDermott, MD – Beth Israel Deaconess Medical Center
###

12:55 PM – 1:00 PM CDT

Introduction: Christopher G. Wood Rising Star Award
Location: Zilker 3-4

Speaker: Bradley C. Leibovich, MD – Mayo Clinic

CME Session

Hybrid Session

Favorite

Bradley C. Leibovich, MD – Mayo Clinic ### 1678492###Speaker###Professor of Urology###Mayo Clinic###
Speaker: Bradley C. Leibovich, MD – Mayo Clinic
###

1:00 PM – 1:05 PM CDT

Christopher G. Wood Rising Star Award Presentation
Location: Zilker 3-4

Award Recipient: Daniel Shapiro, MD – University of Wisconsin-Madison

CME Session

Hybrid Session

Favorite

Daniel Shapiro, MD – University of Wisconsin-Madison ### 1764609###Award Recipient###Urologic Oncology###University of Wisconsin-Madison###
Award Recipient: Daniel Shapiro, MD – University of Wisconsin-Madison
###

1:05 PM – 1:20 PM CDT

Introduction: Nicholas J. Vogelzang Humanitarian Award
Location: Zilker 3-4

Speaker: Brian Rini, MD – Vanderbilt-Ingram Cancer Center

CME Session

Hybrid Session

Favorite

Brian Rini, MD – Vanderbilt-Ingram Cancer Center ### 1678494###Speaker###Chief of Clinical Trials###Vanderbilt-Ingram Cancer Center###
Speaker: Brian Rini, MD – Vanderbilt-Ingram Cancer Center
###

1:20 PM – 1:25 PM CDT

Nicholas J. Vogelzang Humanitarian Award Presentation
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

1:25 PM – 2:25 PM CDT
Session 13: WoodFire®
CME Session
Hybrid Session

1:25 PM – 2:25 PM CDT

Session 13: WoodFire®
Location: Zilker 3-4

CME Session

Hybrid Session

Favorite

1:26 PM – 1:40 PM CDT

Case Discussion 1
Location: Zilker 3-4

Speaker: Daniel Shapiro, MD – University of Wisconsin-Madison

CME Session

Hybrid Session

Favorite

Daniel Shapiro, MD – University of Wisconsin-Madison ### 1764609###Speaker###Urologic Oncology###University of Wisconsin-Madison###
Speaker: Daniel Shapiro, MD – University of Wisconsin-Madison
###

1:40 PM – 1:55 PM CDT

Case Discussion 2
Location: Zilker 3-4

Speaker: Vignesh T. Packiam, MD – University of Iowa

CME Session

Hybrid Session

Favorite

Vignesh T. Packiam, MD – University of Iowa ### 1729292###Speaker###Assistant Professor of Urology###University of Iowa###
Speaker: Vignesh T. Packiam, MD – University of Iowa
###

1:55 PM – 2:10 PM CDT

Case Discussion 3
Location: Zilker 3-4

Speaker: Walter Stadler, MD – University of Chicago

CME Session

Hybrid Session

Favorite

Walter Stadler, MD – University of Chicago ### 1678513###Speaker###Fred C. Buffett Professor of Medicine Dean for Clinical Research Senior Advisor to Director, Comprehensive Cancer Center ###University of Chicago###
Speaker: Walter Stadler, MD – University of Chicago
###

2:10 PM – 2:25 PM CDT

Case Discussion 4
Location: Zilker 3-4

Speaker: Rana McKay, MD – UCSD

CME Session

Hybrid Session

Favorite

Rana McKay, MD – UCSD ### 1698812###Speaker###Associate Professor of Medicine and Urology###UCSD###
Speaker: Rana McKay, MD – UCSD
###

2:25 PM – 2:40 PM CDT
Meeting Closing

2:25 PM – 2:40 PM CDT

Meeting Closing
Location: Zilker 3-4

Speaker: Eric A. Singer, MD, MA, MS, FACS, FASCO – The Ohio State University Comprehensive Cancer Center

Speaker: Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center

CME Session

Hybrid Session

Favorite

Eric A. Singer, MD, MA, MS, FACS, FASCO – The Ohio State University Comprehensive Cancer Center ### 1678482###Speaker###Professor###The Ohio State University Comprehensive Cancer Center###
Speaker: Eric A. Singer, MD, MA, MS, FACS, FASCO – The Ohio State University Comprehensive Cancer Center
### @@@ Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center ### 1570728###Speaker###Associate Professor###University of Texas Southwestern Medical Center###
Speaker: Tian Zhang, MD, MHS – University of Texas Southwestern Medical Center
###